US 9795665
Attenuated live vaccine for Crimean-Congo hemorrhagic fever virus and Erve virus
granted A61KA61K2039/5254A61K39/12
Quick answer
US patent 9795665 (Attenuated live vaccine for Crimean-Congo hemorrhagic fever virus and Erve virus) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/5254, A61K39/12